Blood biomarkers for differential diagnosis and early detection of pancreatic cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Blood biomarkers for differential diagnosis and early detection of pancreatic cancer
Authors
Keywords
Pancreatic cancer, Liquid biopsy, Blood-based biomarkers, Proteins, microRNAs, Circulating tumor DNA (ctDNA), Circulating tumor cells, Differential diagnosis, Early detection
Journal
CANCER TREATMENT REVIEWS
Volume 96, Issue -, Pages 102193
Publisher
Elsevier BV
Online
2021-03-25
DOI
10.1016/j.ctrv.2021.102193
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Serum glycoproteomic-based liquid biopsy for the detection of pancreatic ductal adenocarcinoma.
- (2020) Pashtoon Murtaza Kasi et al. JOURNAL OF CLINICAL ONCOLOGY
- Current Perspectives on Circulating Tumor DNA, Precision Medicine, and Personalized Clinical Management of Cancer
- (2020) Kelly C.S. Oliveira et al. MOLECULAR CANCER RESEARCH
- Impact of circulating tumor DNA in hepatocellular and pancreatic carcinomas
- (2020) Sameer A. Dhayat et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- SST gene hypermethylation acts as a pan-cancer marker for pancreatic ductal adenocarcinoma and multiple other tumors: toward its use for blood-based diagnosis
- (2020) Mehdi Manoochehri et al. Molecular Oncology
- Identification of potential microRNA panels for pancreatic cancer diagnosis using microarray datasets and bioinformatics methods
- (2020) Roshanak Shams et al. Scientific Reports
- Discovery of Pancreatic Adenocarcinoma Biomarkers by Untargeted Metabolomics
- (2020) Ariadna Martín-Blázquez et al. Cancers
- The sTRA Plasma Biomarker: Blinded Validation of Improved Accuracy over CA19-9 in Pancreatic Cancer Diagnosis
- (2019) Ben Staal et al. CLINICAL CANCER RESEARCH
- Exosomes harbor B cell targets in pancreatic adenocarcinoma and exert decoy function against complement-mediated cytotoxicity
- (2019) Michela Capello et al. Nature Communications
- Glycosylation in health and disease
- (2019) Colin Reily et al. Nature Reviews Nephrology
- Early Detection of Pancreatic Cancer: Opportunities and Challenges
- (2019) Aatur D. Singhi et al. GASTROENTEROLOGY
- Vimentin-positive circulating tumor cells as a biomarker for diagnosis and treatment monitoring in patients with pancreatic cancer
- (2019) Tao Wei et al. CANCER LETTERS
- Metabolomics identifies serum and exosomes metabolite markers of pancreatic cancer
- (2019) Lianyuan Tao et al. Metabolomics
- Promoter methylation of ADAMTS1 and BNC1 as potential biomarkers for early detection of pancreatic cancer in blood
- (2019) Maryam A. L. Eissa et al. Clinical Epigenetics
- Circulating tumor DNA quantity is related to tumor volume and both predict survival in metastatic pancreatic ductal adenocarcinoma
- (2019) Marin Strijker et al. INTERNATIONAL JOURNAL OF CANCER
- Liquid biopsy in pancreatic ductal adenocarcinoma: current status of circulating tumor cells and circulating tumor DNA
- (2019) Jee‐Soo Lee et al. Molecular Oncology
- The Expression, Regulation, and Biomarker Potential of Glypican-1 in Cancer
- (2019) Sen Wang et al. Frontiers in Oncology
- Plasma extracellular vesicle long RNA profiling identifies a diagnostic signature for the detection of pancreatic ductal adenocarcinoma
- (2019) Shulin Yu et al. GUT
- The biogenesis, biology and characterization of circular RNAs
- (2019) Lasse S. Kristensen et al. NATURE REVIEWS GENETICS
- Applications of liquid biopsies for cancer
- (2019) Austin K. Mattox et al. Science Translational Medicine
- Quantitative monitoring of circulating tumor DNA in patients with advanced pancreatic cancer undergoing chemotherapy
- (2019) Makoto Sugimori et al. CANCER SCIENCE
- Diagnostic performance for declined microRNA‐133a in pancreatic cancer
- (2019) Zhenyong Wang JOURNAL OF CELLULAR BIOCHEMISTRY
- Circulating Tumor Cells in Pancreatic Cancer: Current Perspectives
- (2019) Verena Martini et al. Cancers
- Periostin and CA242 as potential diagnostic serum biomarkers complementing CA19.9 in detecting pancreatic cancer
- (2018) Dong Dong et al. CANCER SCIENCE
- Exosomal zinc transporter ZIP4 promotes cancer growth and is a novel diagnostic biomarker for pancreatic cancer
- (2018) Haoyi Jin et al. CANCER SCIENCE
- Improved Risk Stratification by Circulating Tumor Cell Counts in Pancreatic Cancer
- (2018) Katharina E. Effenberger et al. CLINICAL CANCER RESEARCH
- Isomer-specific profiling of N-glycans derived from human serum for potential biomarker discovery in pancreatic cancer
- (2018) Yufei Liu et al. Journal of Proteomics
- OUP accepted manuscript
- (2018) JNCI-Journal of the National Cancer Institute
- DNA methylation-based classification of central nervous system tumours
- (2018) David Capper et al. NATURE
- Detection and localization of surgically resectable cancers with a multi-analyte blood test
- (2018) Joshua D. Cohen et al. SCIENCE
- Challenges in diagnosis of pancreatic cancer
- (2018) Lulu Zhang et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Glycoprotein biomarkers for the detection of pancreatic ductal adenocarcinoma
- (2018) Esther Llop et al. WORLD JOURNAL OF GASTROENTEROLOGY
- OUP accepted manuscript
- (2018) JNCI-Journal of the National Cancer Institute
- ctDNA and CTCs in Liquid Biopsy – Current Status and Where We Need to Progress
- (2018) Martin H.D. Neumann et al. Computational and Structural Biotechnology Journal
- Serum Biomarker Signature-Based Liquid Biopsy for Diagnosis of Early-Stage Pancreatic Cancer
- (2018) Linda D. Mellby et al. JOURNAL OF CLINICAL ONCOLOGY
- Circulating Tumor Cells and Cell-Free DNA in Pancreatic Ductal Adenocarcinoma
- (2018) Tamara M.H. Gall et al. AMERICAN JOURNAL OF PATHOLOGY
- Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis
- (2017) Julia Mayerle et al. GUT
- Transcriptional variations in the wider peritumoral tissue environment of pancreatic cancer
- (2017) Andrea S. Bauer et al. INTERNATIONAL JOURNAL OF CANCER
- Glycosylation Changes in Serum Proteins Identify Patients with Pancreatic Cancer
- (2017) Anna Drabik et al. JOURNAL OF PROTEOME RESEARCH
- Detection of early pancreatic ductal adenocarcinoma with thrombospondin-2 and CA19-9 blood markers
- (2017) Jungsun Kim et al. Science Translational Medicine
- Circular RNA circ-LDLRAD3 as a biomarker in diagnosis of pancreatic cancer
- (2017) Fan Yang et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Comparison of the tumor cell secretome and patient sera for an accurate serum-based diagnosis of pancreatic ductal adenocarcinoma
- (2017) Shakhawan Mustafa et al. Oncotarget
- Metabolomic biomarkers of pancreatic cancer: a meta-analysis study
- (2017) Khyati Y. Mehta et al. Oncotarget
- Serum metabolomics differentiating pancreatic cancer from new-onset diabetes
- (2017) Xiangyi He et al. Oncotarget
- Comparative proteomic profiling of the serum differentiates pancreatic cancer from chronic pancreatitis
- (2017) Mayank Saraswat et al. Cancer Medicine
- Biomarker detection technologies and future directions
- (2016) Satish Balasaheb Nimse et al. ANALYST
- Autoantibody Production in Cancer—The Humoral Immune Response toward Autologous Antigens in Cancer Patients
- (2016) P. Zaenker et al. AUTOIMMUNITY REVIEWS
- Identification of a novel serum biomarker for pancreatic cancer, C4b-binding protein α-chain (C4BPA) by quantitative proteomic analysis using tandem mass tags
- (2016) Kazuyuki Sogawa et al. BRITISH JOURNAL OF CANCER
- Circulating Tumor Cells Expressing Markers of Tumor-Initiating Cells Predict Poor Survival and Cancer Recurrence in Patients with Pancreatic Ductal Adenocarcinoma
- (2016) Katherine E. Poruk et al. CLINICAL CANCER RESEARCH
- Clinical Significance of Circulating Tumor Microemboli as a Prognostic Marker in Patients with Pancreatic Ductal Adenocarcinoma
- (2016) M.-C. Chang et al. CLINICAL CHEMISTRY
- Analysis of Base-Position Error Rate of Next-Generation Sequencing to Detect Tumor Mutations in Circulating DNA
- (2016) Nicolas Pécuchet et al. CLINICAL CHEMISTRY
- Detection of Hot-Spot Mutations in Circulating Cell-Free DNA From Patients With Intraductal Papillary Mucinous Neoplasms of the Pancreas
- (2016) Andreas W. Berger et al. GASTROENTEROLOGY
- The potential diagnostic value of serum microRNA signature in patients with pancreatic cancer
- (2016) Julia S. Johansen et al. INTERNATIONAL JOURNAL OF CANCER
- Dysbindin as a novel biomarker for pancreatic ductal adenocarcinoma identified by proteomic profiling
- (2016) Xin Guo et al. INTERNATIONAL JOURNAL OF CANCER
- Plasma miR-22-3p, miR-642b-3p and miR-885-5p as diagnostic biomarkers for pancreatic cancer
- (2016) Neveen Abd El Moneim Hussein et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Clinical significance of pancreatic circulating tumor cells using combined negative enrichment and immunostaining-fluorescence in situ hybridization
- (2016) Yang Gao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- PIM-1 contributes to the malignancy of pancreatic cancer and displays diagnostic and prognostic value
- (2016) Jianwei Xu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Sequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic Cancer
- (2016) Michela Capello et al. JNCI-Journal of the National Cancer Institute
- A High Circulating Tumor Cell Count in Portal Vein Predicts Liver Metastasis From Periampullary or Pancreatic Cancer
- (2016) Yu Wen Tien et al. MEDICINE
- Plasma protein profiling in a stage defined pancreatic cancer cohort - Implications for early diagnosis
- (2016) Anna Sandström Gerdtsson et al. Molecular Oncology
- Genomic analyses identify molecular subtypes of pancreatic cancer
- (2016) Peter Bailey et al. NATURE
- Serum Metabolite Profiling for the Detection of Pancreatic Cancer
- (2016) Hirofumi Akita et al. PANCREAS
- In VivoFlow Cytometry of Circulating Tumor-Associated Exosomes
- (2016) Jacqueline Nolan et al. Analytical Cellular Pathology
- Serum IgG4 and IgG for the diagnosis of autoimmune pancreatitis: A systematic review with meta-analysis
- (2016) Ming-Jian Lian et al. Clinics and Research in Hepatology and Gastroenterology
- A systematic review of serum autoantibodies as biomarkers for pancreatic cancer detection
- (2016) Karin Dumstrei et al. Oncotarget
- Reg proteins promote acinar-to-ductal metaplasia and act as novel diagnostic and prognostic markers in pancreatic ductal adenocarcinoma
- (2016) Qing Li et al. Oncotarget
- New combined microRNA and protein plasmatic biomarker panel for pancreatic cancer
- (2016) Wei Yuan et al. Oncotarget
- Sequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic Cancer
- (2016) Michela Capello et al. JNCI-Journal of the National Cancer Institute
- Improved Pancreatic Adenocarcinoma Diagnosis in Jaundiced and Non-Jaundiced Pancreatic Adenocarcinoma Patients through the Combination of Routine Clinical Markers Associated to Pancreatic Adenocarcinoma Pathophysiology
- (2016) María José Ferri et al. PLoS One
- Identification of IGFBP2 and IGFBP3 As Compensatory Biomarkers for CA19-9 in Early-Stage Pancreatic Cancer Using a Combination of Antibody-Based and LC-MS/MS-Based Proteomics
- (2016) Toshihiro Yoneyama et al. PLoS One
- Specific MAPK-Associated MicroRNAs in Serum Differentiate Pancreatic Cancer from Autoimmune Pancreatitis
- (2016) Manabu Akamatsu et al. PLoS One
- Applicative Value of Serum CA19-9, CEA, CA125 and CA242 in Diagnosis and Prognosis for Patients with Pancreatic Cancer Treated by Concurrent Chemoradiotherapy
- (2015) Yu-Lei Gu et al. Asian Pacific Journal of Cancer Prevention
- High Levels of Cell-Free Circulating Nucleic Acids in Pancreatic Cancer are Associated With Vascular Encasement, Metastasis and Poor Survival
- (2015) Nidhi Singh et al. CANCER INVESTIGATION
- Recent Advances in Autoimmune Pancreatitis
- (2015) Phil A. Hart et al. GASTROENTEROLOGY
- Circulating Epithelial Cells in Patients with Pancreatic Lesions: Clinical and Pathologic Findings
- (2015) Christy E. Cauley et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
- (2015) Sonia A. Melo et al. NATURE
- Clinicopathological Significance of Leucine-Rich α2-Glycoprotein-1 in Sera of Patients With Pancreatic Cancer
- (2015) Kenta Furukawa et al. PANCREAS
- Addressing the challenges of pancreatic cancer: Future directions for improving outcomes
- (2015) Manuel Hidalgo et al. PANCREATOLOGY
- Proteomics analysis of bodily fluids in pancreatic cancer
- (2015) Sheng Pan et al. PROTEOMICS
- Pancreatic cancer serum biomarker PC-594: Diagnostic performance and comparison to CA19-9
- (2015) Shawn A Ritchie WORLD JOURNAL OF GASTROENTEROLOGY
- Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients
- (2015) Mark Sausen et al. Nature Communications
- Cell-Free DNA Next-Generation Sequencing in Pancreatobiliary Carcinomas
- (2015) O. A. Zill et al. Cancer Discovery
- Metabolomic profile in pancreatic cancer patients: a consensus-based approach to identify highly discriminating metabolites
- (2015) Iole Maria Di Gangi et al. Oncotarget
- Plasma biomarker for detection of early stage pancreatic cancer and risk factors for pancreatic malignancy using antibodies for apolipoprotein-AII isoforms
- (2015) Kazufumi Honda et al. Scientific Reports
- Circulating nucleosomes as epigenetic biomarkers in pancreatic cancer
- (2015) Monika Bauden et al. Clinical Epigenetics
- SELEX Aptamer Used as a Probe to Detect Circulating Tumor Cells in Peripheral Blood of Pancreatic Cancer Patients
- (2015) Jinqiang Zhang et al. PLoS One
- MicroRNA Markers for the Diagnosis of Pancreatic and Biliary-Tract Cancers
- (2015) Motohiro Kojima et al. PLoS One
- Clinical utility of circulating tumor DNA for molecular assessment in pancreatic cancer
- (2015) Erina Takai et al. Scientific Reports
- Utility of serum IgG, IgG4 and carbonic anhydrase II antibodies in distinguishing autoimmune pancreatitis from pancreatic cancer and chronic pancreatitis
- (2014) Renata Talar-Wojnarowska et al. Advances in Medical Sciences
- miRNAs can be generally associated with human pathologies as exemplified for miR-144*
- (2014) Andreas Keller et al. BMC Medicine
- Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
- (2014) L. Rahib et al. CANCER RESEARCH
- Combined evaluation of a panel of protein and miRNA serum-exosome biomarkers for pancreatic cancer diagnosis increases sensitivity and specificity
- (2014) Bindhu Madhavan et al. INTERNATIONAL JOURNAL OF CANCER
- MicroRNA Biomarkers in Whole Blood for Detection of Pancreatic Cancer
- (2014) Nicolai A. Schultz et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Serum peptide signatures for pancreatic cancer based on mass spectrometry: a comparison to CA19-9 levels and routine imaging techniques
- (2014) Berit Velstra et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Glycoprotein Biomarker Panel for Pancreatic Cancer Discovered by Quantitative Proteomics Analysis
- (2014) Song Nie et al. JOURNAL OF PROTEOME RESEARCH
- Serum cytokine biomarker panels for discriminating pancreatic cancer from benign pancreatic disease
- (2014) Victoria E Shaw et al. Molecular Cancer
- Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development
- (2014) Jared R Mayers et al. NATURE MEDICINE
- Clinical relevance of circulating cell-free microRNAs in cancer
- (2014) Heidi Schwarzenbach et al. Nature Reviews Clinical Oncology
- Chondroitin Sulfate Proteoglycan CSPG4 as a Novel Hypoxia-Sensitive Marker in Pancreatic Tumors
- (2014) Shereen Keleg et al. PLoS One
- Combined detection of serum UL16-binding protein 2 and macrophage inhibitory cytokine-1 improves early diagnosis and prognostic prediction of pancreatic cancer
- (2014) YU-FEN ZHOU et al. Oncology Letters
- iTRAQ reveals candidate pancreatic cancer serum biomarkers: influence of obstructive jaundice on their performance
- (2013) S Tonack et al. BRITISH JOURNAL OF CANCER
- A Novel Serum Metabolomics-Based Diagnostic Approach to Pancreatic Cancer
- (2013) T. Kobayashi et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Novel Methylation Biomarker Panel for the Early Detection of Pancreatic Cancer
- (2013) J. M. Yi et al. CLINICAL CANCER RESEARCH
- MicroRNA Array Analysis Finds Elevated Serum miR-1290 Accurately Distinguishes Patients with Low-Stage Pancreatic Cancer from Healthy and Disease Controls
- (2013) A. Li et al. CLINICAL CANCER RESEARCH
- Modelling the benefits of early diagnosis of pancreatic cancer using a biomarker signature
- (2013) Ola Ghatnekar et al. INTERNATIONAL JOURNAL OF CANCER
- Development of serum parameters panels for the early detection of pancreatic cancer
- (2013) Pengjun Zhang et al. INTERNATIONAL JOURNAL OF CANCER
- Clinical utility of high-throughput glycome analysis in patients with pancreatic cancer
- (2013) Kazuhiro Nouso et al. JOURNAL OF GASTROENTEROLOGY
- Clinical Significance of Serum COL6A3 in Pancreatic Ductal Adenocarcinoma
- (2013) Christopher Y. Kang et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models
- (2013) Michela Capello et al. Journal of Hematology & Oncology
- Elevated Serum Levels of Circulating Immunoinflammation-Related Protein Complexes Are Associated with Cancer
- (2013) Yanying Wang et al. JOURNAL OF PROTEOME RESEARCH
- The failure of protein cancer biomarkers to reach the clinic: why, and what can be done to address the problem?
- (2012) Eleftherios P Diamandis BMC Medicine
- Identification of Serum Biomarker Signatures Associated with Pancreatic Cancer
- (2012) C. Wingren et al. CANCER RESEARCH
- Serum high mobility group box-1 is a powerful diagnostic and prognostic biomarker for pancreatic ductal adenocarcinoma
- (2012) Hye Won Chung et al. CANCER SCIENCE
- EMT and Dissemination Precede Pancreatic Tumor Formation
- (2012) Andrew D. Rhim et al. CELL
- Reevaluation of a lectin antibody ELISA kit for measuring fucosylated haptoglobin in various conditions
- (2012) Yoshihiro Kamada et al. CLINICA CHIMICA ACTA
- The expressions and clinical significances of tissue and serum galectin-3 in pancreatic carcinoma
- (2012) Ling Xie et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Pancreatic carcinoma, pancreatitis, and healthy controls: metabolite models in a three-class diagnostic dilemma
- (2012) Alexander Benedikt Leichtle et al. Metabolomics
- Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer
- (2011) R Morimura et al. BRITISH JOURNAL OF CANCER
- Detection of apoptotic circulating tumor cells in advanced pancreatic cancer following 5-fluorouracil chemotherapy
- (2011) Chuanli Ren et al. CANCER BIOLOGY & THERAPY
- Pancreatitis-Induced Inflammation Contributes to Pancreatic Cancer by Inhibiting Oncogene-Induced Senescence
- (2011) Carmen Guerra et al. CANCER CELL
- Serum Biomarker Panels for the Detection of Pancreatic Cancer
- (2011) R. E. Brand et al. CLINICAL CANCER RESEARCH
- Serum MicroRNA Expression Profile as a Biomarker in the Diagnosis and Prognosis of Pancreatic Cancer
- (2011) R. Liu et al. CLINICAL CHEMISTRY
- A multiplexed bead assay for profiling glycosylation patterns on serum protein biomarkers of pancreatic cancer
- (2011) Chen Li et al. ELECTROPHORESIS
- Combination of plasma microRNAs with serum CA19-9 for early detection of pancreatic cancer
- (2011) Jianqiang Liu et al. INTERNATIONAL JOURNAL OF CANCER
- Toward the blood-borne miRNome of human diseases
- (2011) Andreas Keller et al. NATURE METHODS
- Clinical Profile of Autoimmune Pancreatitis and Its Histological Subtypes
- (2011) Terumi Kamisawa et al. PANCREAS
- Enhanced Discrimination of Malignant from Benign Pancreatic Disease by Measuring the CA 19-9 Antigen on Specific Protein Carriers
- (2011) Tingting Yue et al. PLoS One
- Discovery of serum biomarkers for pancreatic adenocarcinoma using proteomic analysis
- (2010) A Xue et al. BRITISH JOURNAL OF CANCER
- Differential methylation of cell-free circulating DNA among patients with pancreatic cancer versus chronic pancreatitis
- (2010) Thomas Liggett et al. CANCER
- A Migration Signature and Plasma Biomarker Panel for Pancreatic Adenocarcinoma
- (2010) S. Balasenthil et al. Cancer Prevention Research
- Soluble iC3b as an Early Marker for Pancreatic Adenocarcinoma Is Superior to CA19.9 and Radiology
- (2010) Angela Märten et al. JOURNAL OF IMMUNOTHERAPY
- Circulating Autoantibodies to Phosphorylated α-Enolase are a Hallmark of Pancreatic Cancer
- (2010) Barbara Tomaino et al. JOURNAL OF PROTEOME RESEARCH
- Marker Expression in Circulating Cancer Cells of Pancreatic Cancer Patients
- (2010) Jiahua Zhou et al. JOURNAL OF SURGICAL RESEARCH
- Distant metastasis occurs late during the genetic evolution of pancreatic cancer
- (2010) Shinichi Yachida et al. NATURE
- Incidence and characteristics of chronic and lymphoplasmacytic sclerosing pancreatitis in patients scheduled to undergo a pancreatoduodenectomy
- (2010) Steve M.M. De Castro et al. HPB
- Likelihood ratios of clinical, laboratory and image data of pancreatic cancer: Bayesian approach
- (2009) Esteban de Icaza et al. JOURNAL OF EVALUATION IN CLINICAL PRACTICE
- Pancreatic Cancer Serum Detection Using a Lectin/Glyco-Antibody Array Method
- (2008) Chen Li et al. JOURNAL OF PROTEOME RESEARCH
- Antibodypedia, a Portal for Sharing Antibody and Antigen Validation Data
- (2008) Erik Björling et al. MOLECULAR & CELLULAR PROTEOMICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More